Login Register Cart 0
Generic placeholder image

Current Alzheimer Research

Editor-in-Chief

ISSN (Print): 1567-2050
ISSN (Online): 1875-5828

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe Translate in Chinese
Case Report

Dysexecutive Alzheimer’s Disease with Lewy Body Disease Co-Pathology

Author(s): Ryan P. Coburn, Hugo Botha, Jonathan Graff-Radford, R. Ross Reichard, David T. Jones and Vijay K. Ramanan*

Volume 19, Issue 4, 2022

Published on: 30 March, 2022

Page: [330 - 333] Pages: 4

DOI: 10.2174/1567205019666220308152219

Price: $65

Abstract

Background: Alzheimer’s disease can present atypically as a progressive dysexecutive syndrome (dAD), an entity that preferentially affects younger individuals and is frequently misdiagnosed, highlighting the imperative for additional research.

Objective: The objective of this study is to characterize the clinical, antemortem neuroimaging, and postmortem neuropathologic features of two cases of young-onset dAD who displayed evidence of Lewy body disease (LBD) co-pathology at autopsy.

Methods: Clinical histories, antemortem MRI and PET imaging, and postmortem neuropathologic data were reviewed for each patient.

Case Presentation: Canonical features of dAD were observed in both cases, including progressive and predominant impairment in tasks related to working memory and cognitive flexibility, a lack of major behavioral/personality changes, and evidence of abnormal amyloid and tau deposition by antemortem amyloid and tau PET and postmortem neuropathology. Relative sparing of hippocampal involvement was observed in both individuals, in keeping with many cases of clinically atypical AD. One of the patients developed subtle parkinsonian signs as well as paranoia and irritability in the years prior to passing. In both cases, transitional (brainstem and limbic) LBD co-pathology was observed at autopsy.

Results and Discussion: Although LBD co-pathology is not uncommon in AD overall, the presence of LBD pathology in these young-onset cases of dAD (including a case with apparent symptomatic correlate) warrants further investigation for broader frequency and underlying pathophysiology.

Conclusion: A better understanding of which specific young-onset AD phenotypes are associated with LBD co-pathology would have important implications for counseling, treatment, clinical trial enrollment, and knowledge on disease mechanisms.

Keywords: Alzheimer’s disease, atypical AD, Lewy body disease, case report, neuropathology, MRI, PET.

« Previous
[1]
Townley RA, Graff-Radford J, Mantyh WG, et al. Progressive dysexecutive syndrome due to Alzheimer's disease: A description of 55 cases and comparison to other phenotypes. Brain Commun 2020; 2: fcaa068.
[http://dx.doi.org/10.1093/braincomms/fcaa068]
[2]
Graff-Radford J, Yong KXX, Apostolova LG, et al. New insights into atypical Alzheimer’s disease in the era of biomarkers. Lancet Neurol 2021; 20(3): 222-34.
[http://dx.doi.org/10.1016/S1474-4422(20)30440-3] [PMID: 33609479]
[3]
Kokmen E, Naessens JM, Offord KP. A short test of mental status: Description and preliminary results. Mayo Clin Proc 1987; 62(4): 281-8.
[http://dx.doi.org/10.1016/S0025-6196(12)61905-3] [PMID: 3561043]
[4]
Montine TJ, Phelps CH, Beach TG, et al. National institute on Aging-Alzheimer’s association guidelines for the neuropathologic assessment of Alzheimer’s disease: A practical approach. Acta Neuropathol 2012; 123(1): 1-11.
[http://dx.doi.org/10.1007/s00401-011-0910-3] [PMID: 22101365]
[5]
Jones DT, Graff-Radford J. Executive dysfunction and the prefrontal cortex. Continuum (Minneap Minn) 2021; 27(6): 1586-601.
[http://dx.doi.org/10.1212/CON.0000000000001009] [PMID: 34881727]
[6]
Graff-Radford J, Murray ME, Lowe VJ, et al. Dementia with Lewy bodies: Basis of cingulate island sign. Neurology 2014; 83(9): 801-9.
[http://dx.doi.org/10.1212/WNL.0000000000000734] [PMID: 25056580]
[7]
Nedelska Z, Kantarci K. Reply to letter: Basis of cingulate island sign may differ in dementia with lewy bodies and posterior cortical atrophy. Mov Disord 2019; 34(5): 761-2.
[http://dx.doi.org/10.1002/mds.27677] [PMID: 31091363]
[8]
Robinson JL, Lee EB, Xie SX, et al. Neurodegenerative disease concomitant proteinopathies are prevalent, age-related and APOE4-associated. Brain 2018; 141(7): 2181-93.
[http://dx.doi.org/10.1093/brain/awy146] [PMID: 29878075]
[9]
Beach TG, Malek-Ahmadi M. Alzheimer’s Disease neuropathological comorbidities are common in the younger-old. J Alzheimers Dis 2021; 79(1): 389-400.
[http://dx.doi.org/10.3233/JAD-201213] [PMID: 33285640]
[10]
Chung EJ, Babulal GM, Monsell SE, Cairns NJ, Roe CM, Morris JC. Clinical features of Alzheimer Disease with and without lewy bodies. JAMA Neurol 2015; 72(7): 789-96.
[http://dx.doi.org/10.1001/jamaneurol.2015.0606] [PMID: 25985321]
[11]
Cairns NJ, Perrin RJ, Franklin EE, et al. Neuropathologic assessment of participants in two multi-center longitudinal observational studies: The Alzheimer Disease Neuroimaging Initiative (ADNI) and the Dominantly Inherited Alzheimer Network (DIAN). Neuropathology 2015; 35(4): 390-400.
[http://dx.doi.org/10.1111/neup.12205] [PMID: 25964057]
[12]
Hanna Al-Shaikh FS, Duara R, Crook JE, et al. Selective vulnerability of the nucleus basalis of meynert among neuropathologic subtypes of Alzheimer Disease. JAMA Neurol 2020; 77(2): 225-33.
[http://dx.doi.org/10.1001/jamaneurol.2019.3606] [PMID: 31657834]
[13]
Spina S, La Joie R, Petersen C, et al. Comorbid neuropathological diagnoses in early versus late-onset Alzheimer’s disease. Brain 2021; 144(7): 2186-98.
[http://dx.doi.org/10.1093/brain/awab099] [PMID: 33693619]
[14]
Leverenz JB, Fishel MA, Peskind ER, et al. Lewy body pathology in familial Alzheimer disease: Evidence for disease- and mutation-specific pathologic phenotype. Arch Neurol 2006; 63(3): 370-6.
[http://dx.doi.org/10.1001/archneur.63.3.370] [PMID: 16533963]

Rights & Permissions Print Cite
Article Metrics
39
2
© 2024 Bentham Science Publishers | Privacy Policy